Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06548061 · ClinicalTrials.gov registry record · NA
D20054;LITT for Spine Tumors
A NA study of Spinal Metastases, sponsored by Dartmouth-Hitchcock Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06548061: Recruiting NA study of Spinal Metastases, sponsored by Dartmouth-Hitchcock Medical Center.
NCT06548061 is a NA study of Spinal Metastases that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 25 participants, below the 113-participant average among 5 other Spinal Metastases trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06548061, a NA study of Spinal Metastases, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates of local tumor control are comparable between conventional open surgical techniques and spinal laser interstitial therapy.
Primary Outcome
Any increase in the epidural spinal cord compression score (ESCC grade 1 (no compression) to 3 (spinal cord compression) compared to the initial post-procedure MRI will be considered local radiographic failure or evidence of tumor recurrence.
Conditions Studied
Interventions
- DEVICE ClearPoint Prism
Study Locations (1)
New Hampshire
- Dartmouth Health - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-05-16 |
| Est. Completion | 2029-06-01 |
| Phase | NA |
What NCT06548061 shows while recruiting
NCT06548061 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 113-participant average among 5 other Spinal Metastases trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Spinal Metastases appearing as the primary indexed condition, and to 1 intervention - of which ClearPoint Prism is the first listed.
NCT06548061 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT06548061 about?
NCT06548061 is a clinical study titled "D20054;LITT for Spine Tumors". The objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates of local tumor control are comparable between conventional open surgical techniques and spinal laser...
What is the current status of trial NCT06548061?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-05-16. Estimated completion is 2029-06-01.
What conditions does trial NCT06548061 study?
This clinical trial studies the following conditions: Spinal Metastases.
What interventions are being tested in trial NCT06548061?
The interventions under investigation include: ClearPoint Prism (DEVICE).
Who is sponsoring clinical trial NCT06548061?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06548061 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stereotactic Body Radiotherapy for Spine Tumors
COMPLETED · NA
-
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
RECRUITING · Phase 3
-
A Prospective Study of Performing MRI Simulation in Treatment Position in Spinal Stereotactic Body Radiation Therapy
ACTIVE NOT RECRUITING
-
Validation of Novel Predictive Score for Patients With Spinal Metastases
COMPLETED
-
Intra-arterial Chemotherapy for Spinal Metastases
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI